// App-Quantinova.ai

3821 : Targeted therapy for head and neck squamous cell carcinoma using the novel SMAC-mimetic birinapant

Researchers

Presenter

  • Adeeb Derakhshan

Principal Investigators

  • Danielle Eytan

  • Grace Snow

  • Sophie Carlson

  • Anthony Saleh

  • Hui Cheng

  • Stephen Schiltz

  • Suresh Mohan

  • Shaleeka Cornelius

  • Jamie Coupar

  • Anastasia Sowers

  • Lydia Hernandez

  • James Mitchell

  • Christina Annunziata

  • Zhong Chen

  • Carter Van Waes

Medical Centers

  • National Institute of Health, Bethesda, MD

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Squamous cell carcinoma of the head and neck

  • Gynaecological cancer

  • Solid malignancies

Biomarkers

  • TNF superfamily member 10

  • Tumor necrosis factor

Drug/Treatment

  • TL32711

  • birinapant

Outcome

  • N/A


Study Design

  • N/A

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A